Novartis AG is 79.9x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($283.13 B vs $3.54 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EWTX | NVS |
|---|---|---|
| Market cap | $3.54 B | $283.13 B |
| US-listed rank | #1678 | #47 |
| Net income (latest FY) | -$167.79K | - |
| SEC filings | 384 | 947 |
Novartis AG is 79.9x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($283.13 B vs $3.54 B).
Full pages: Edgewise Therapeutics, Inc. and Novartis AG, or browse the full rankings.